Sylvie Shen

1.2k total citations · 1 hit paper
26 papers, 840 citations indexed

About

Sylvie Shen is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Sylvie Shen has authored 26 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Hematology. Recurrent topics in Sylvie Shen's work include Acute Myeloid Leukemia Research (4 papers), RNA Interference and Gene Delivery (4 papers) and Immune Cell Function and Interaction (4 papers). Sylvie Shen is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), RNA Interference and Gene Delivery (4 papers) and Immune Cell Function and Interaction (4 papers). Sylvie Shen collaborates with scholars based in Australia, Italy and Sweden. Sylvie Shen's co-authors include Carol A. Pollock, Alla Dolnikov, Xinming Chen, Geoff Symonds, Toby Passioura, Chunling Huang, Qing Ma, Jayne Murray, Luigi Lerra and Jourdin R.C. Rouaen and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Sylvie Shen

26 papers receiving 831 citations

Hit Papers

Intratumoral Copper Modulates PD-L1 Expression and Influe... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Shen Australia 14 447 202 177 171 123 26 840
Gregory Dyson United States 20 577 1.3× 304 1.5× 326 1.8× 142 0.8× 97 0.8× 74 1.1k
Samuel A. Kerk United States 15 611 1.4× 240 1.2× 282 1.6× 176 1.0× 98 0.8× 21 967
Jeong‐Hun Ko United Kingdom 14 467 1.0× 131 0.6× 100 0.6× 157 0.9× 189 1.5× 23 781
Shigeru Tomoyasu Japan 22 718 1.6× 356 1.8× 148 0.8× 99 0.6× 113 0.9× 90 1.3k
Christina Ravera United States 9 716 1.6× 554 2.7× 145 0.8× 111 0.6× 94 0.8× 15 1.3k
Jack Leslie United Kingdom 17 396 0.9× 184 0.9× 208 1.2× 117 0.7× 174 1.4× 34 1.1k
Chun Deng China 15 565 1.3× 299 1.5× 152 0.9× 180 1.1× 315 2.6× 40 1.2k
Fei Yue China 14 649 1.5× 227 1.1× 140 0.8× 103 0.6× 114 0.9× 32 972
Young Yiul Lee South Korea 14 335 0.7× 185 0.9× 113 0.6× 52 0.3× 41 0.3× 27 722
Joo Heon Kim South Korea 21 773 1.7× 411 2.0× 294 1.7× 300 1.8× 169 1.4× 60 1.4k

Countries citing papers authored by Sylvie Shen

Since Specialization
Citations

This map shows the geographic impact of Sylvie Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Shen more than expected).

Fields of papers citing papers by Sylvie Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Shen. The network helps show where Sylvie Shen may publish in the future.

Co-authorship network of co-authors of Sylvie Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Shen. A scholar is included among the top collaborators of Sylvie Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Shen. Sylvie Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voli, Florida, Emanuele Valli, Luigi Lerra, et al.. (2020). Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Research. 80(19). 4129–4144. 280 indexed citations breakdown →
2.
Voli, Florida, Luigi Lerra, Kathleen Kimpton, et al.. (2019). Abstract 3224: Copper homeostasis: A new player in anti-tumor immune response. Cancer Research. 79(13_Supplement). 3224–3224. 3 indexed citations
3.
Xu, Ning, Sylvie Shen, & Alla Dolnikov. (2016). Increasing Stem Cell Dose Promotes Posttransplant Immune Reconstitution. Stem Cells and Development. 26(7). 461–470. 4 indexed citations
4.
Shen, Sylvie. (2016). Stem Cell Approach to Generate Cancer Specific Immune Effectors Cells. 3(1). 1 indexed citations
5.
Dolnikov, Alla, Sylvie Shen, Swapna Joshi, et al.. (2015). Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia. Experimental Hematology. 43(12). 1001–1014.e5. 13 indexed citations
6.
Shen, Sylvie, Ning Xu, Dávid Ma, et al.. (2014). Small-Molecule Inhibitor of Glycogen Synthase Kinase 3β 6-Bromoindirubin-3-oxime Inhibits Hematopoietic Regeneration in Stem Cell Recipient Mice. Stem Cells and Development. 24(6). 724–736. 14 indexed citations
7.
Komala, Muralikrishna Gangadharan, Simon Gross, Harshini Mudaliar, et al.. (2014). Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice. PLoS ONE. 9(11). e108994–e108994. 62 indexed citations
8.
Dolnikov, Alla, Ning Xu, Sylvie Shen, et al.. (2014). Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy. Blood. 124(21). 5813–5813. 1 indexed citations
9.
Shen, Sylvie, et al.. (2013). GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice. Experimental Hematology. 41(12). 1016–1027.e1. 8 indexed citations
10.
Chen, Xinming, Sylvie Shen, Swarna Lekha Vijayaraj, et al.. (2013). Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling. PLoS ONE. 8(8). e73428–e73428. 41 indexed citations
11.
Cheng, Delfine, Sylvie Shen, Xinming Chen, Carol A. Pollock, & Filip Braet. (2013). Application of transmission electron tomography for modeling the renal corpuscle. Pathology - Research and Practice. 209(11). 731–734. 2 indexed citations
12.
Shen, Sylvie, Emma Song, Alison Rice, et al.. (2012). GSK3 inhibition prevents lethal GVHD in mice. Experimental Hematology. 41(1). 39–55.e10. 13 indexed citations
13.
Millington, Michelle, et al.. (2009). Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34+ Hematopoietic Stem/Progenitor Cells. PLoS ONE. 4(7). e6461–e6461. 38 indexed citations
14.
McIntyre, Glen, et al.. (2009). 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology. 6(1). 55–55. 32 indexed citations
15.
McIntyre, Glen, Anna H. Tran, Michelle Millington, et al.. (2009). Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success. Virology Journal. 6(1). 184–184. 18 indexed citations
16.
Shen, Sylvie, Toby Passioura, Geoff Symonds, & Alla Dolnikov. (2007). N-ras oncogene–induced gene expression in human hematopoietic progenitor cells: Upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation. Experimental Hematology. 35(6). 908–919. 10 indexed citations
17.
Palladinetti, Patricia, Toby Passioura, Sylvie Shen, et al.. (2006). The Role of IRF1 and IRF2 Transcription Factors in Leukaemogenesis. Current Gene Therapy. 6(5). 543–550. 19 indexed citations
18.
Passioura, Toby, Alla Dolnikov, Sylvie Shen, & Geoff Symonds. (2005). N-Ras –Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1. Cancer Research. 65(3). 797–804. 28 indexed citations
19.
Shen, Sylvie, Alla Dolnikov, Toby Passioura, et al.. (2004). Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse. Experimental Hematology. 32(9). 852–860. 23 indexed citations
20.
Dolnikov, Alla, Sylvie Shen, Michelle Millington, et al.. (2003). A sensitive dual-fluorescence reporter system enables positive selection of ras suppressors by suppression of ras-induced apoptosis. Cancer Gene Therapy. 10(10). 745–754. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026